Risks related with withholding and resuming anticoagulation in patients with non-variceal upper gastrointestinal bleeding while on warfarin therapy

International Journal of Clinical Practice

Volumn 66, Issue 1, 2012, Pages 64-68

  Lee, J K ^a   Kang, H W ^a   Kim, S G ^b   Kim, J S ^b   Jung, H C ^b  

^a Dongguk University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD TRANSFUSION; CONTROLLED STUDY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMOSTASIS; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOEMBOLISM; TREATMENT FAILURE; UPPER GASTROINTESTINAL BLEEDING;

ANTICOAGULANTS; CASE-CONTROL STUDIES; DRUG SUBSTITUTION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REFUSAL TO TREAT; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 83755164203     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02827.x     Document Type: Article

References (35)

1. Petersen P, Boysen G, Godtfredsen J, et al., Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1: 175-9. (Pubitemid 19038801)
2. Ezekowitz MD, Bridgers SL, James KE, et al., Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. Veterans affairs stroke prevention in non-rheumatic atrial fibrillation investigators. N Engl J Med 1992; 327: 1406-12.
3. Sam C, Massaro JM, D'Agostino RB Sr, et al., Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study). Am J Cardiol 2004; 94: 947-51. (Pubitemid 39349566)
4. Pengo V, Pegoraro C, Cucchini U, Iliceto S,. Worldwide management of oral anticoagulant therapy: the ISAM study. J Thromb Thrombolysis 2006; 21: 73-7. (Pubitemid 43231132)
5. Levine MN, Raskob G, Landefeld S, Kearon C,. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119: 108S-21S. (Pubitemid 32154197)
6. Choudari CP, Palmer KR,. Acute gastrointestinal haemorrhage in patients treated with anticoagulant drugs. Gut 1995; 36: 483-4.
7. Vallurupalli NG, Goldhaber SZ,. Gastrointestinal complications of dual antiplatelet therapy. Circulation 2006; 113: e655-8. (Pubitemid 43739403)
8. Bhatt DL, Scheiman J, Abraham NS, et al., ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2008; 52: 1502-17.
9. Weil J, Colin-Jones D, Langman M, et al., Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-30.
10. Sorensen HT, Mellemkjaer L, Blot WJ, et al., Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000; 95: 2218-24.
11. Cryer B, Feldman M,. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999; 117: 17-25. (Pubitemid 29297615)
12. Derry S, Loke YK,. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000; 321: 1183-7.
13. Laine L, Maller ES, Yu C, et al., Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology 2004; 127: 395-402. (Pubitemid 39091887)
14. Ng FH, Wong SY, Chang CM, et al., High incidence of clopidogrel- associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 2003; 18: 443-9. (Pubitemid 37070243)
15. Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O,. Clinical outcome in upper gastrointestinal bleeding complicating low-dose aspirin and antithrombotic drugs. Aliment Pharmacol Ther 2006; 24: 633-6. (Pubitemid 44127844)
16. Lai KC, Lam SK, Chu KM, et al., Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346: 2033-8. (Pubitemid 34680594)
17. Chan FK, Ching JY, Hung LC, et al., Clopidogrel vs. aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005; 352: 238-44. (Pubitemid 40110812)
18. Kelly JP, Kaufman DW, Jurgelon JM, et al., Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996; 348: 1413-6. (Pubitemid 26395236)
19. Battistella M, Mamdami MM, Juurlink DN, et al., Risk of upper gastrointestinal hemorrhage in warfarin users treated with non-selective NSAIDs or COX-2 inhibitors. Arch Inter Med 2005; 165: 189-92.
20. Thomopoulos KC, Mimidis KP, Theocharis GJ, et al., Acute upper gastrointestinal bleeding in patients on long-term oral anticoagulation therapy: endoscopic findings, clinical management and outcome. World J Gastroenterol 2005; 11: 1365-8. (Pubitemid 40425922)
21. Rubin TA, Murdoch M, Nelson DB,. Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: endoscopic diagnosis, clinical management, and outcomes. Gastrointest Endosc 2003; 58: 369-73. (Pubitemid 38220235)
22. Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al., Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with non-steroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol 2007; 102: 507-15. (Pubitemid 46328156)
23. Eisen GM, Baron TH, Dominitz JA, et al., Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002; 55: 775-9.
24. Lau JY, Chung SC, Leung JW, et al., The evolution of stigmata of hemorrhage in bleeding peptic ulcers: a sequential endoscopic study. Endoscopy 1998; 30: 513-8. (Pubitemid 28409967)
25. Katholi RE, Nolan SP, McGuire LB,. Living with prosthetic heart valves. Subsequent non-cardiac operations and the risk of thromboembolism or hemorrhage. Am Heart J 1976; 92: 162-7.
26. Tinker JH, Tarhan S,. Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations. JAMA 1978; 239: 738-9. (Pubitemid 8276469)
27. Garcia DA, Regan S, Henault LE, et al., Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 2008; 168: 63-9.
28. Carrel TP, Klingenmann W, Mohacsi PJ, et al., Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis 1999; 8: 392-8. (Pubitemid 29396394)
29. Torn M, Rosendaal FR,. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 2003; 123: 676-82. (Pubitemid 37468065)
30. Jaffer AK, Ahmed M, Brotman DJ, et al., Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol. J Thromb Thrombolysis 2005; 20: 11-6. (Pubitemid 41300615)
31. Douketis JD, Johnson JA, Turpie AG,. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004; 164: 1319-26. (Pubitemid 38828883)
32. Jafri SM,. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004; 147: 3-15. (Pubitemid 38040083)
33. Kuwada SK, Balm R, Gostout CJ,. The risk of withdrawing chronic anticoagulation because of acute GI bleeding. Am J Gastroenterol 1996; 91: 1116-9. (Pubitemid 26175467)
34. Wolf AT, Wasan SK, Saltzman JR,. Impact of anticoagulation on rebleeding following endoscopic therapy for non-variceal upper gastrointestinal hemorrhage. Am J Gastroenterol 2007; 102: 290-6. (Pubitemid 46160542)
35. Marmo R, Rotondano G, Bianco MA, et al., Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis. Gastrointest Endosc 2003; 57: 62-7. (Pubitemid 36236801)